Campbell & Co Investment Adviser’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Campbell & Co Investment Adviser's NEO Position: Q2 2026 in Review
Campbell & Co Investment Adviser sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 350,891 shares — an estimated $2.6M sold.
Campbell & Co Investment Adviser first reported a position in NEO in Q2 2016 and held it in 20 quarters. The position peaked at $2.6M in Q1 2026. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Campbell & Co Investment Adviser reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 350,891 NeoGenomics shares in Q2 2026, an estimated $2.6M.
- Campbell & Co Investment Adviser first reported a position in NeoGenomics in Q2 2016 and held it in 20 quarters.
- Campbell & Co Investment Adviser's NeoGenomics position peaked at $2.6M in Q1 2026.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.